Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest autoimmune disease Stories

2014-04-18 09:59:31

Attack by own immune system may kill neurons in Parkinson's disease The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the way autoimmune diseases like type I diabetes, celiac disease, and multiple sclerosis attack the body's cells. The study was published April 16, 2014, in Nature Communications. "This is a new, and likely controversial,...

2014-04-11 12:54:50

Too much of a protein called c-FLIPR can trigger autoimmune diseases Apoptosis is used by cells that are changed by disease or are simply not needed any longer to eliminate themselves before they become a hazard to the body—on a cellular level, death is part of life. Disruption of this process can lead to cancer or immunodeficiencies, but also to autoimmune diseases, in which cells attack their own body. HZI scientist Prof Ingo Schmitz and his team investigate the regulation of...

2014-04-10 23:30:57

The Children's Medical Safety Research Institute is proud to announce Claire Dwoskin of the Dwoskin Family Foundation was awarded for her philanthropic efforts in Nice, France, at the 2014 Autoimmunity Congress. Fairfax, VA (PRWEB) April 10, 2014 Claire Dwoskin, founder of the Children Medical Safety Research Institute (CMSRI), was presented with one of three awards that recognize people who contribute in a significant way to the field of Autoimmunity. During the 2014 Autoimmunity...

2014-04-07 12:33:36

Investment fuels expansion of industry-leading immunosequencing research platform and diagnostic products for the treatment of cancer, autoimmune disorders, and infectious diseases SEATTLE, April 7, 2014 /PRNewswire/ -- Adaptive Biotechnologies announced today the completion of the Company's Series C financing round and the completion of a newly created Series D round with a $105 million investment from Viking Global Investors. This investment will enable the Company to expand...

2014-04-01 13:02:44

Antibiotics being explored for the treatment of cystic fibrosis and muscular dystrophy have the potential to trigger autoimmune disease The code for every gene includes a message at the end of it that signals the translation machinery to stop. Some diseases, such as cystic fibrosis and Duchenne muscular dystrophy, can result from mutations that insert this stop signal into the middle of an essential gene, causing the resulting protein to be truncated. Some antibiotics cause the cell's...

2014-03-31 16:27:04

Health Insurance Claim Data Suggests Value of Screening BOSTON, March 31, 2014 /PRNewswire-USNewswire/ -- Patients with an autoimmune disease have a 3.8-fold increased risk of developing epilepsy, according to a new population-level study from Boston Children's Hospital based on health insurance claim data. The study, published online March 31, 2014 in JAMA Neurology, is the largest to date to look at the association between autoimmune disease and epilepsy without a recognized...

2014-03-26 08:29:10

GAITHERSBURG, Md., March 26, 2014 /PRNewswire/ -- The HealthWell Foundation, an independent non-profit providing nationwide financial assistance to insured Americans with high out-of-pocket medication expenses, today announced the launch of a new fund to assist patients suffering from chronic idiopathic urticaria. The fund provides copayment assistance to eligible patients to help ease the burden of medical costs to treat the condition. Urticaria is a condition that typically...

2014-03-12 04:21:02

CARMEL, Calif., March 12, 2014 /PRNewswire/ -- Autoimmune diseases are one of the top 10 leading causes of death in female children and women in all age groups up to 64 years of age. While common immunosuppressant treatments frequently lead to devastating long-term side effects, the NIH estimates up to 23.5 million Americans suffer from autoimmune disease and that number is rising. Life is a significant challenge for those suffering from autoimmune disorders. Many continue to struggle...

2014-03-07 12:25:28

TBG and TNIB join forces to address the critical need for quality treatments to combat chronic, life-threatening diseases in developing countries around the world MINNEAPOLIS and ORLANDO, Fla., March 7, 2014 /PRNewswire/ -- The Brewer Group, Inc. ("TBG") a global investment advisory firm, today announced a new strategic partnership with TNI BioTech, Inc. ("TNIB") (OTCQB: TNIB), a biotechnology company pioneering the development of innovative therapies for autoimmune diseases by...

2014-03-06 12:27:02

ORLANDO, Fla., March 6, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC: TNIB) announced today that it has formed a new subsidiary, Cytocom, Inc., for the purpose of developing Low Dose Naltrexone (LDN) and Met-enkephalin (MENK). TNI BioTech has spent the last year developing a manufacturing and distribution network for sale of LDN into emerging nations and has had discussions with the FDA and EMA to begin clinical trials in the United States. The Company has considered whether to...